Related Experiment Videos
Drug delivery to the cochlea using PLGA nanoparticles
Tetsuya Tamura1, Tomoko Kita, Takayuki Nakagawa
1Department of Otolaryngology-Head and Neck Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
The Laryngoscope
|December 2, 2005
Summary
Poly lactic/glycolic acid (PLGA) nanoparticles effectively deliver therapeutic molecules to the cochlea when applied locally to the round window membrane. This local application enhances targeted drug delivery compared to systemic administration.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Otolaryngology
Background:
- Drug delivery to the cochlea is challenging due to its complex anatomy.
- Poly lactic/glycolic acid (PLGA) nanoparticles offer potential for targeted therapeutic molecule delivery.
- Developing effective cochlear drug delivery systems is crucial for treating hearing disorders.
Purpose of the Study:
- To evaluate the efficacy of PLGA nanoparticles for cochlear drug delivery.
- To compare local versus systemic administration of PLGA nanoparticles for cochlear targeting.
- To assess the biodistribution and cochlear permeation of PLGA nanoparticles.
Main Methods:
- An experimental study using guinea pigs.
- Rhodamine-labeled PLGA nanoparticles were administered systemically and locally to the round window membrane (RWM).
- Rhodamine fluorescence was quantified in the cochlea, liver, and kidney.
Main Results:
- Systemic nanoparticle administration showed sustained delivery to the liver but not the cochlea or kidney.
- PLGA nanoparticles applied locally to the RWM successfully permeated into the scala tympani.
- Local RWM application of PLGA nanoparticles resulted in more effective cochlear targeting than systemic delivery.
Conclusions:
- PLGA nanoparticles are a viable drug carrier for cochlear delivery.
- Local application to the RWM is a superior strategy for targeted cochlear drug delivery using PLGA nanoparticles.